Rising Obesity Rates: A Global Threat Obesity, a chronic metabolic disease, has significantly impacted the health and quality of life...

What if a single cellular pathway could unlock new therapies for muscle regeneration, cancer, obesity, immune system regulation, and more?...

November 14, 2024 Base Therapeutics announced that its independently developed NK510 cell injection, the world's first base-edited universal NK cell...

With the first CRISPR gene-editing drug approved for over ten months now, what exciting developments are there in CRISPR drug...

Recent studies have shown that various drugs, including small molecules, opioids, and antibiotics, can activate MRGPRX2 (Mas-related G-protein coupled receptor...

Gene therapy is marking new frontiers with the recent FDA approvals of innovative treatments for sickle cell disease (SCD). Casgevy...

How VLPs are unlocking the next generation of antibody therapeutics for challenging transmembrane proteins Transmembrane proteins play crucial roles in...

For years, recombinant major histocompatibility complexes (MHCs) have been expressed in bacterial systems with in vitro refolding. While this preserves...

What are virus-like particles (VLPs)? Virus-like particles (VLPs) are nanoparticle structures (50-300nm diameter) that mimic the organization and conformation of...

Introducing Neoantigen-Based Immunotherapy Neoantigen-based immunotherapy is revolutionizing cancer treatment by focusing on neoantigens—unique proteins formed by mutations in cancer cells....

After successful IND approval this past July, we are excited to announce the NK therapy NK510 received clinical trial approval from...

In a groundbreaking development for the biotech industry, KACTUS's GMP-grade Cas9 has critically helped Yizun Bio secure IND clearance for a universal...